NCT03006796View on ClinicalTrials.gov

Observational Study of Azilsartan/Chlorthalidone and Irbesartan/Hydrochlorothiazide in Hypertension and Obesity.

CompletedOBSERVATIONAL
Enrollment

94

Participants

Timeline

Start Date

January 16, 2017

Primary Completion Date

February 29, 2020

Study Completion Date

March 31, 2020

Conditions
Arterial Hypertension
Trial Locations (1)

107015

City Hospital №5, Moscow

All Listed Sponsors
lead

Russian Heart Failure Society

OTHER

NCT03006796 - Observational Study of Azilsartan/Chlorthalidone and Irbesartan/Hydrochlorothiazide in Hypertension and Obesity. | Biotech Hunter | Biotech Hunter